Back to search
FDAFDA · Food and drugs·Recall number D-1137-2016

Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5.

Published July 13, 2016 · Recall initiated: March 23, 2016

Summary

FDA records drug Class I recall D-1137-2016, published July 13, 2016 and initiated March 23, 2016. Recalling firm: Hospira Inc.; Status: Ongoing; Reported quantity: 88,500 vials; Lot: Lot #: 50-343-DK*, Exp 01FEB2017; note that the lot number may be followed by numbers from 01 to 99. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide, United Arab Emirates, Kuwait, and Bahrain
Lot
Lot #: 50-343-DK*, Exp 01FEB2017; note that the lot number may be followed by numbers from 01 to 99.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Magnesium Sulfate Inj., USP 50%, 10 g/20 mL (0.5 g/mL), (4 mEq Magnesium/mL, 20 mL Single-dose vial, packaged in 25 vials per box, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-2168-02, barcode (01) 2 030409 216802 5. recalled?

Yes. FDA published recall D-1137-2016 on July 13, 2016. Reported hazard: Presence of Particulate Matter: Confirmed customer complaint for the presence of particulate matter.

What should I do if I have this product?

Voluntary: Firm initiated · Letter